More Images
NEEDHAM, Mass.—BostonSight, a nonprofit eye health care organization and research center dedicated to saving sight and improving quality of life for patients across the globe, announced today they have formed a scientific advisory board comprising medical experts to help guide BostonSight’s robust research initiatives. “BostonSight has always pursued excellence and pushed the limits when it comes to understanding corneal health,” said Sara Yost, BostonSight president and CEO. “As leaders in the eye health industry, we’re excited to bring together medical experts to provide expertise and guidance as we plan future studies that will advance the understanding, treatment, and care of complex corneal disease.”

The BostonSight scientific advisory board, chaired by Dan Brocks, MD, BostonSight’s chief medical officer, includes Yost along with Demi Niforos, MS, vice president of biostatistics and statistical programming at eClinical Solutions; Michael Raizman, MD, a practitioner at Ophthalmic Consultants of Boston and associate professor of ophthalmology at Tufts University School of Medicine; Ali Djalilian, MD, professor of ophthalmology, cornea service and director of the Stem Cell Therapy and Corneal Tissue Engineering Laboratory at Illinois Eye and Ear Infirmary; and Gloria B. Chiu, OD, FAAO, FSLS, associate professor of clinical ophthalmology at the USC Roski Eye Institute, department of ophthalmology at the University of Southern California Keck School of Medicine.

“Our research program brings together BostonSight, our partners, and patients to improve existing treatments and explore cutting-edge therapeutic modalities for corneal disease,” said Brocks. “A robust research program pushes the industry forward by educating the medical community and inspiring new treatment protocols, ultimately improving patient outcomes.”